Nasal Drug Delivery Systems Market, By Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, and Others), By Container Type (Non-pressurized Containers, and Pressurized Containers), By System Type (Multi-dose, Bi-dose, and Unit dose), By Therapeutic Application (Allergic and Non-allergic Rhinitis, Nasal Congestion, Vaccination, and Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Report Code: PMI25219 | Publish Date: May 2022 | No. of Pages: 145

Global Nasal Drug Delivery Systems Overview

Administration of drug trough nasal route is referred as nasal drug delivery system which is an alternative to invasive administrations and provides direct access to systemic circulation. Nasal drug delivery is most preferred route of administration in treatment of allergic and non-allergic rhinitis, nasal congestion, and common cold. Intranasal route can be cross the blood brain barrier and deliver the drug molecules to the central nervous system. The drugs are also been administered via nasal route for therapeutic and recreational purpose, with the help of nasal drug delivery systems. Nasal drug delivery is advisable for drugs undergoing extensive first pass effect. Further, intranasal route is also exploited for bypassing the blood brain barrier and delivery the drugs molecules to the central nervous system. The nasal drug delivery systems are different for different drug, depending on their formation, as liquid nasal preparations are administered through inhalers, droppers, spray pumps, atomizers, or nebulizers. The Global Nasal Drug Delivery Market accounted for US$ 51.20 billion in 2020 and is estimated to be US$ 92.47 billion by 2030 and is anticipated to register a CAGR of 6.1%

Global Nasal Drug Delivery Systems Dynamics

                                                     

Increasing awareness regarding nasal drug delivery

The increasing awareness regarding the nasal drug delivery drives the nasal drug delivery systems market. Further, the advantages such as, drug degradation that is observed in gastrointestinal tract is absent, hepatic first pass metabolism is avoided, rapid drug absorption and many more, which increase the adoption of nasal drug delivery systems, in turn propelling the nasal drug delivery market.

Increasing prevalence of diseases

Additionally, with increasing prevalence of diseases is also expected to foster the market of nasal drug delivery systems. For instance, in 2017, according to Journal of Allergy and Clinical Immunology, the prevalence of asthma in developed cities of Asia Pacific such as, Japan, Hong Kong, and Singapore is high as 12.4%.

Furthermore, the technological advancement is also bringing new products into the market. For instance, in 2017, Optinose, an ENT/Allergy specialty pharmaceutical company, received New Drug Application approval for its Xhance, fluticasone propionate, for the indication of nasal polyps in adults.

Global Nasal Drug Delivery Systems Segmentation

                                        

Global nasal drug delivery systems market is segmented on the basis of dosage form, container type, system type, therapeutic application, distribution channel, and region.

On the basis of dosage form, the global nasal drug delivery systems market is categorized into nasal spray, nasal drops, nasal gels, nasal powders, and others. On the basis of system type, the target market is segmented into multi-dose, bi-dose, and unit dose. On the basis of therapeutic applications, the target market is segmented into allergic and non-allergic rhinitis, nasal congestion, vaccination, and others. On the basis of distribution channel, the global nasal drug delivery system is categorized into market hospitals pharmacies, retail pharmacies, and online pharmacies.

Regional Insights:

                                    

For detailed understanding of market dynamics, On the basis of region, the global nasal drug delivery system market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The market in North America is expected to account for major revenue share as compared to that of other regions. This can be attributed to rising research and development by local manufacturers to develop new drug device or delivery system combination. Also, the market in Europe is expected to account for second-highest revenue share in the global market, followed by the market in Asia Pacific.

 

                                          

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2030

Market Segmentation

By Dosage Form- Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, And Others

By Container Type- Non-Pressurized and Pressurized Container

By System Type- Multi-Dose, Bi-Dose, And Unit Dose

By Therapeutic Application- Allergic And Non-Allergic Rhinitis, Nasal Congestion, Vaccination, And Others

By Distribution Channel- Hospitals Pharmacies, Retail Pharmacies, And Online Pharmacies.

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Detailed Segmentation:

Global Nasal Drug Delivery Systems Market, By Dosage Form:

  • Nasal Spray
  • Nasal Drops
  • Nasal Gels
  • Nasal Powders
  • Others

Global Nasal Drug Delivery Systems Market, Container Type:

  • Non-pressurized Containers
  • Pressurized Containers

Global Nasal Drug Delivery Systems Market, By System Type:

  • Multi-dose
  • Bi-dose
  • Unit dose

Global Nasal Drug Delivery Systems Market, By Therapeutic Application:

  • Allergic and Non-allergic Rhinitis
  • Nasal Congestion
  • Vaccination
  • Others

Global Nasal Drug Delivery Systems Market, By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Nasal Drug Delivery Systems Market, By Region:

o    North America

  • North America Nasal Drug Delivery Systems Market, By Dosage Form
  • North America Nasal Drug Delivery Systems Market, By Container Type
  • North America Nasal Drug Delivery Systems Market, By System Type
  • North America Nasal Drug Delivery Systems Market, By Therapeutic Application
  • North America Nasal Drug Delivery Systems Market, By Distribution Channel
  • North America Nasal Drug Delivery Systems Market, By Country
  • U.S.
  • Canada

o    Europe

  • Europe Nasal Drug Delivery Systems Market, By Dosage Form
  • Europe Nasal Drug Delivery Systems Market, By Container Type
  • Europe Nasal Drug Delivery Systems Market, By System Type
  • Europe Nasal Drug Delivery Systems Market, By Therapeutic Application
  • Europe Nasal Drug Delivery Systems Market, By Distribution Channel
  • Europe Nasal Drug Delivery Systems Market, By Country
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Switzerland
  • Sweden
  • Rest of Europe

o    Asia-Pacific

  • Asia-Pacific Nasal Drug Delivery Systems Market, By Dosage Form
  • Asia Pacific Nasal Drug Delivery Systems Market, By Container Type
  • Asia-Pacific Nasal Drug Delivery Systems Market, By System Type
  • Asia-Pacific Nasal Drug Delivery Systems Market, By Therapeutic Application
  • Asia-Pacific Nasal Drug Delivery Systems Market, By Distribution Channel
  • Asia-Pacific Nasal Drug Delivery Systems Market, By Country
  • China
  • India
  • Australia & New Zealand
  • Japan
  • South Korea
  • Rest of Asia Pacific

o    Latin America

  • Latin America Nasal Drug Delivery Systems Market, By Dosage Form
  • Latin America Nasal Drug Delivery Systems Market, By Container Type
  • Latin America Nasal Drug Delivery Systems Market, By System Type
  • Latin America Nasal Drug Delivery Systems Market, By Therapeutic Application
  • Latin America Nasal Drug Delivery Systems Market, By Distribution Channel
  • Latin America Nasal Drug Delivery Systems Market, By Country
  • Brazil
  • Mexico
  • Argentina and Chile
  • Rest of Latin America

o    Middle East

  • Middle East Nasal Drug Delivery Systems Market, By Dosage Form
  • Middle East Nasal Drug Delivery Systems Market, By Container Type
  • Middle East Nasal Drug Delivery Systems Market, By System Type
  • Middle East Nasal Drug Delivery Systems Market, By Therapeutic Application
  • Middle East Nasal Drug Delivery Systems Market, By Distribution Channel
  • Middle East Nasal Drug Delivery Systems Market, By Country
  • GCC
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East

o    Africa

  • Africa Nasal Drug Delivery Systems Market, By Dosage Form
  • Africa Nasal Drug Delivery Systems Market, By Container Type
  • Africa Nasal Drug Delivery Systems Market, By System Type
  • Africa Nasal Drug Delivery Systems Market, By Therapeutic Application
  • Africa Nasal Drug Delivery Systems Market, By Distribution Channel
  • Africa Nasal Drug Delivery Systems Market, By Country
  • North Africa
  • Central Africa
  • South Africa

Global Nasal Drug Delivery Systems Key Players

                                                                                     

Key players operating in the global nasal drug delivery system market Merck & Co., GlaxoSmithKline plc., AstraZeneca plc., Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG. For Instance,  in 2019, Aptar Pharma, a leading drug delivery systems provider, is pleased to announce that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. This marks the first FDA approval and U.S. launch of a prescription drug using Aptar Pharma’s patented Bidose nasal spray delivery system.

Global Nasal Drug Delivery Systems Company Profile

o     Merck & Co.

  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategy Overview

o       GlaxoSmithKline plc

  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategy Overview
  • AstraZeneca plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategy Overview
  • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategy Overview
  • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategy Overview
  • Baxter International, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategy Overview
  • Valeant Pharmaceuticals International, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategy Overview
  • Becton, Dickinson and Company
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategy Overview
  • Novartis AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategy Overview

Global Nasal Drug Delivery Systems Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Nasal Drug Delivery Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Dosage Form
      • Market Snippet, By Container Type
      • Market Snippet, By System Type
      • Market Snippet, By Therapeutic Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Nasal Drug Delivery Market, By Dosage Form,  2020 – 2030, (US$ Mn)
    • Overview          
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Nasal Spray
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Nasal Drops
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Nasal Gels
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Nasal Powders
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Nasal Drug Delivery Market, By System Type, 2020 – 2030, (US$ Mn)
    • Overview         
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Multi-Dose
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Bi-Dose
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Unit-Dose
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Nasal Drug Delivery Market, By Container Type, 2020 – 2030, (US$ Mn)
    • Overview         
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Non-Pressurized Container
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pressurized Container
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Global Nasal Drug Delivery Market, By Therapeutic Application, 2020 – 2030, (US$ Mn)
    • Overview         
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Allergic and Non-Allergic Rhinitis
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Nasal Congestion
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Vaccination
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Others
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  9. Global Nasal Drug Delivery Market, By Distribution Channel, 2020 – 2030, (US$ Mn)
    • Overview         
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Retail Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Online Pharmacies
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  10. Global Nasal Drug Delivery Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  11. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  12. Company Profiles
      • Stryker Corporation
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • First Data Corp
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • Worldpay Inc.
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • Chetu
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • Paypal
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • Wirecard
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • Fiserv
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • Total System Services (TSYS)
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • Novatti
        • Company Overview 
        • Product Portfolio
        • Key Highlights
      • Financial Performance
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • Global Payments
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance
      • Bluesnap
        • Company Overview 
        • Product Portfolio
        • Key Highlights
        • Financial Performance

The Last Word

    • Future Impact
    • About Us
    • Contact

FAQs

The global digital payment solutions market report segments the market on the basis of type, application, and region.

Contactless payments help reduce customer queues and hassles, and supply better leads to the shape of upper revenue for retailers.

Asia-Pacific has the largest market in terms of revenue due to increasing proliferation of smartphones enabling e-commerce and rise in the ecommerce sales and growth in internet penetration in this region.

Some of the prominent players operating in the global digital payment solutions market include First Data Corp, Worldpay Inc., Chetu, Paypal, Wirecard, Fiserv, Total System Services (TSYS), Novatti, Global Payments, and Bluesnap.